Sonoma Pharmaceuticals, Inc. - SIC # 2647 -

Ticker Exchange SIC # Website Latest Ticker
SNOA Nasdaq 2647 sonomapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices - Dec 5th, 2024 1:30 pm
Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock - Nov 27th, 2024 1:50 pm
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - Nov 21st, 2024 9:06 pm
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - Nov 11th, 2024 9:20 pm
Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Nov 9th, 2024 1:12 pm
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - Nov 7th, 2024 1:45 pm
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - Oct 31st, 2024 8:01 pm
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - Oct 22nd, 2024 12:35 pm
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - Oct 21st, 2024 8:01 pm
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule - Sep 19th, 2024 12:30 pm
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution - Sep 17th, 2024 12:30 pm
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line - Sep 11th, 2024 12:30 pm
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock - Aug 28th, 2024 10:10 am
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff - Aug 26th, 2024 12:30 pm
Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States - Aug 21st, 2024 12:45 pm
Sonoma Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations - Aug 11th, 2024 12:02 pm
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results - Aug 8th, 2024 8:10 pm
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum - Jul 15th, 2024 12:50 pm
Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine - Jul 9th, 2024 11:30 am
Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain Stock - Jun 28th, 2024 12:50 pm